Clinical Trial Update: ODM-207 in Patients With Advance Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ODM-207 in patients with advanced solid tumors across Phase 1 and Phase 2 concluded.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ODM-207

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED